Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 307
Dvorak, V, Casiraghi, A, Colas, C, Koren, A, Tomek, T, Offensperger, F, Rukavina, A, Tin, G, Hahn, E, Dobner, S, Frommelt, F, Boeszoermenyi, A, Bernada, V, Hannich, JT, Ecker, GF, Winter, GE, Kubicek, S & Superti-Furga, G 2023, 'Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors', Cell Chemical Biology, vol. 30, no. 8, pp. 953-964.e9. https://doi.org/10.1016/j.chembiol.2023.06.029

Activities

Non-linear methods and machine learning in drug discovery

Gerhard Ecker
ESMEC - European School of Medicinal Chemistry
Summer/Winter school, Talk or oral contribution
6.7.2006 - 6.7.2006

In vitro and in silico models for prediction of P-glycoprotein substrates

Gerhard Ecker
Talk or oral contribution
27.6.2006 - 27.6.2006

A flow based hollow-fiber blood-brain barrier in vitro model with immortalised cell line PBMEC/C1-2

Gerhard Ecker
Gordon Research Conference 2006: Barriers of the CNS
Conference, Talk or oral contribution
25.6.2006 - 25.6.2006

P-glycoprotein - From target to antitarget

Gerhard Ecker
Talk or oral contribution
7.4.2006 - 7.4.2006

Pharmacoinformatic approaches to target polyspecific proteins

Gerhard Ecker
Talk or oral contribution
21.2.2006 - 21.2.2006